Turgeon J - Search Results

1

Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells.

Leung YH, Turgeon J, Michaud V. Leung YH, et al. Among authors: turgeon j. Pharmaceutics. 2017 Oct 10;9(4):42. doi: 10.3390/pharmaceutics9040042. Pharmaceutics. 2017. PMID: 28994701 Free PMC article.

2

Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone.

Simard C, Michaud V, Gibbs B, Massé R, Lessard E, Turgeon J. Simard C, et al. Among authors: turgeon j. Xenobiotica. 2004 Nov-Dec;34(11-12):1013-23. doi: 10.1080/00498250400015301. Xenobiotica. 2004. PMID: 15801545

3

Understanding clopidogrel efficacy in the presence of cytochrome P450 polymorphism.

Turgeon J, Pharand C, Michaud V. Turgeon J, et al. CMAJ. 2006 Jun 6;174(12):1729. doi: 10.1503/cmaj.060502. CMAJ. 2006. PMID: 16754901 Free PMC article. No abstract available.

4

Inhibitory effects of propafenone on the pharmacokinetics of caffeine in humans.

Michaud V, Mouksassi MS, Labbé L, Bélanger PM, Ferron LA, Gilbert M, Grech-Bélanger O, Turgeon J. Michaud V, et al. Among authors: turgeon j. Ther Drug Monit. 2006 Dec;28(6):779-83. doi: 10.1097/01.ftd.0000249945.64978.33. Ther Drug Monit. 2006. PMID: 17164694

5

An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies.

Michaud V, Simard C, Turgeon J. Michaud V, et al. Among authors: turgeon j. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):611-6. doi: 10.1016/j.jchromb.2007.02.044. Epub 2007 Mar 12. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17379582

6

Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patients.

Michaud V, Vanier MC, Brouillette D, Roy D, Verret L, Noel N, Taillon I, O'Hara G, Gossard D, Champagne M, Goodman K, Renaud Y, Brown A, Phillips M, Ajami AM, Turgeon J. Michaud V, et al. Among authors: turgeon j. Clin Pharmacol Ther. 2008 May;83(5):740-8. doi: 10.1038/sj.clpt.6100434. Epub 2007 Nov 14. Clin Pharmacol Ther. 2008. PMID: 18030307

7

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination.

Fenneteau F, Turgeon J, Couture L, Michaud V, Li J, Nekka F. Fenneteau F, et al. Among authors: turgeon j. Theor Biol Med Model. 2009 Jan 15;6:2. doi: 10.1186/1742-4682-6-2. Theor Biol Med Model. 2009. PMID: 19146691 Free PMC article.

8

Assessment of competitive and mechanism-based inhibition by clarithromycin: use of domperidone as a CYP3A probe-drug substrate and various enzymatic sources including a new cell-based assay with freshly isolated human hepatocytes.

Michaud V, Turgeon J. Michaud V, et al. Among authors: turgeon j. Drug Metab Lett. 2010 Apr;4(2):69-76. doi: 10.2174/187231210791292717. Drug Metab Lett. 2010. PMID: 20446912

9

Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism.

Michaud V, Frappier M, Dumas MC, Turgeon J. Michaud V, et al. Among authors: turgeon j. PLoS One. 2010 Dec 14;5(12):e15666. doi: 10.1371/journal.pone.0015666. PLoS One. 2010. PMID: 21179487 Free PMC article.

10

Characterization of CYP3A isozymes involved in the metabolism of domperidone: role of cytochrome b5 and inhibition by ketoconazole.

Michaud V, Simard C, Turgeon J. Michaud V, et al. Among authors: turgeon j. Drug Metab Lett. 2010 Apr;4(2):95-103. doi: 10.2174/187231210791292735. Drug Metab Lett. 2010. PMID: 21281268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters